The U.S. Food and Drug Administration (FDA) has agreed to review an application seeking approval of Axsome Therapeutics‘ experimental…
Marisa Horak, MS
Marisa holds an MS in Cellular and Molecular Pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. She specializes in cancer biology, immunology, and genetics. Marisa began working with BioNews in 2018, and has written about science and health for SelfHacked and the Genetics Society of America. She also writes/composes musicals and coaches the University of Pittsburgh fencing club.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Horak, MS
Long-term treatment with the experimental oral therapy alixorexton safely improved wakefulness, eased fatigue, and boosted cognition for people with…
Type 1 narcolepsy has long been linked to the loss of nerve cells called hypocretin neurons in a brain…
In adults with narcolepsy type 1 (NT1), a specific brain region called the hypothalamus is smaller than in people…